epirubicin has been researched along with Response Evaluation Criteria in Solid Tumors in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Basilico, F; Bezzi, M; Catalano, C; Corona, M; De Rubeis, G; Ginanni Corradini, L; Lucatelli, P | 1 |
| Albrecht, T; Gross, A | 1 |
| Kawamoto, C; Kumita, SI; Miki, I; Murakami, R; Murata, S; Saito, H; Sugihara, F; Uchida, E; Uchiyama, F; Ueda, T; Yamaguchi, H; Yasui, D | 1 |
| Basilico, F; Bezzi, M; Cannavale, A; Catalano, C; Corona, M; De Rubeis, G; Ginnani Corradini, L; Lucatelli, P; Nardis, PG; Rocco, B; Saba, L | 1 |
| Brüning, R; Habbel, VSA; Oldhafer, KJ; Rodt, T; Stavrou, GA; Wacker, F; Zeile, M | 1 |
| Guo, QY; Liang, HY; Lu, ZM; Mao, XN; Shan, M; Sun, W; Wang, XH; Wen, F; Zhao, G | 1 |
6 other study(ies) available for epirubicin and Response Evaluation Criteria in Solid Tumors
| Article | Year |
|---|---|
Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC, in course of degradable starch microsphere TACE.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cone-Beam Computed Tomography; Epirubicin; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Prognosis; Prospective Studies; Radiography, Interventional; Response Evaluation Criteria in Solid Tumors; ROC Curve; Sensitivity and Specificity; Starch; Statistics, Nonparametric; Time Factors; Treatment Outcome | 2019 |
Transarterial Chemoembolisation (TACE) with Degradable Starch Microspheres (DSM) and Anthracycline in Patients with Locally Extensive Hepatocellular Carcinoma (HCC): Safety and Efficacy.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Prognosis; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Starch; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy.
Topics: Aged; Aged, 80 and over; Angiography; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Ethiodized Oil; Female; Femoral Artery; Hepatic Artery; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Portal Vein; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Rate | 2017 |
Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Balloon Occlusion; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Multimodal Imaging; Polyethylene Glycols; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Correlation between SACE (Subjective Angiographic Chemoembolization Endpoint) score and tumor response and its impact on survival after DEB-TACE in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed | 2019 |
Sequential Use of Transhepatic Arterial Chemoembolization and Bipolar Radiofrequency Ablation in the Clinical Therapy of Hepatocellular Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Cyclobutanes; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Rate; Tumor Burden | 2015 |